VERU INC. Accumulated Other Comprehensive Income
VERU INC. (VERU) had Accumulated Other Comprehensive Income of $0 as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-10
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 |
| 2025-09-30 | $0.00 10-Q · filed 2026-08-10 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-13 |
| 2024-09-30 | -$581.52K 10-K · filed 2025-12-17 |
| 2024-06-30 | -$581.52K 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$581.52K 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$581.52K 10-Q · filed 2024-04-01 |
| 2023-09-30 | -$581.52K 10-K · filed 2024-12-16 |
| 2023-06-30 | -$581.52K 10-Q/A · filed 2023-11-15 |
| 2023-03-31 | -$581.52K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$581.52K 10-Q · filed 2023-02-09 |
| 2022-09-30 | -$581.52K 10-K/A · filed 2024-04-01 |
| 2022-06-30 | -$581.52K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$581.52K 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$581.52K 10-Q · filed 2022-02-09 |
| 2021-09-30 | -$581.52K 10-K · filed 2022-12-05 |
| 2021-06-30 | -$581.52K 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$581.52K 10-Q · filed 2021-05-12 |
| 2020-12-31 | -$581.52K 10-Q · filed 2021-02-10 |
| 2020-09-30 | -$581.52K 10-K · filed 2021-12-02 |
| 2020-06-30 | -$581.52K 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$581.52K 10-Q · filed 2020-05-13 |
| 2019-12-31 | -$581.52K 10-Q · filed 2020-02-12 |
| 2019-09-30 | -$581.52K 10-K · filed 2020-12-10 |
| 2019-06-30 | -$581.52K 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$581.52K 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$581.52K 10-Q · filed 2019-02-13 |
| 2018-09-30 | -$581.52K 10-K · filed 2019-12-12 |
| 2018-06-30 | -$581.52K 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$581.52K 10-Q · filed 2018-05-11 |
| 2017-12-31 | -$581.52K 10-Q · filed 2018-02-14 |
| 2017-09-30 | -$581.52K 10-K · filed 2018-12-13 |
| 2017-06-30 | -$581.52K 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$581.52K 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$581.52K 10-Q · filed 2017-02-09 |
| 2016-09-30 | -$581.52K 10-K · filed 2018-01-02 |
| 2016-06-30 | -$581.52K 10-Q · filed 2016-07-28 |
| 2016-03-31 | -$581.52K 10-Q · filed 2016-04-28 |
| 2015-12-31 | -$581.52K 10-Q · filed 2016-02-02 |
| 2015-09-30 | -$581.52K 10-K · filed 2016-12-12 |
| 2015-06-30 | -$581.52K 10-Q · filed 2015-07-30 |
| 2015-03-31 | -$581.52K 10-Q · filed 2015-04-30 |
| 2014-12-31 | -$581.52K 10-Q · filed 2015-02-03 |
| 2014-09-30 | -$581.52K 10-K · filed 2015-12-02 |
| 2014-06-30 | -$581.52K 10-Q · filed 2014-07-31 |
| 2014-03-31 | -$581.52K 10-Q · filed 2014-05-01 |
| 2013-12-31 | -$581.52K 10-Q · filed 2014-02-03 |
| 2013-09-30 | -$581.52K 10-K · filed 2014-12-02 |
| 2013-06-30 | -$581.52K 10-Q · filed 2013-08-01 |
| 2013-03-31 | -$581.52K 10-Q · filed 2013-05-02 |
| 2012-12-31 | -$581.52K 10-Q · filed 2013-01-30 |
| 2012-09-30 | -$581.52K 10-K · filed 2013-12-03 |
| 2012-06-30 | -$581.52K 10-Q · filed 2012-07-31 |
| 2012-03-31 | -$581.52K 10-Q · filed 2012-05-01 |
| 2011-12-31 | -$581.52K 10-Q · filed 2012-01-31 |
| 2011-09-30 | -$581.52K 10-K · filed 2012-12-04 |
| 2011-06-30 | -$581.52K 10-Q · filed 2011-08-05 |
| 2010-09-30 | -$581.52K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |